Ketorolac tromethamine - Incorrect Polymorph

CAS : 74103-07-4

Ref. 3D-IK58066

Informations sur le produit

• Nom: Ketorolac tromethamine - Incorrect Polymorph
• Synonymes: 1H-Pyrrolizine-1-carboxylic acid, 5-benzoyl-2,3-dihydro-, (±)-, compd. with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1), incorre ct polymorph, (+/-)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid tris(hydroxymethyl)methylamine salt, 1,3-Propanediol, 2-amino-2-(hydroxymethyl)-, (±)-5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylate (1:1) (salt), 1,3-Propanediol, 2-amino-2-(hydroxymethyl)-, benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylate (1:1) (salt), 1H-Pyrrolizine-1-carboxylic acid, 5-benzoyl-2,3-dihydro-, (±)-, compd. with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1), 5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid-2-amino-2-(hydroxymethyl)propane-1,3-diol (1:1), Acular, Acular PF, Acuvail, Dolac, Isv 304, Ketanov, Ketolac, Ketorol, Ketorolac tris salt, Ketorolac trometamol, Lixidol, Tarazyn, Toradol, Toratex, Trometamol Ketorolac

Description

Ketorolac tromethamine is a nonsteroidal anti-inflammatory drug (NSAID) that inhibits prostaglandin synthesis. It has been shown to be effective in the treatment of pain and inflammation, but is often associated with gastrointestinal ulceration. Ketorolac tromethamine is a crystalline form of ketorolac that is made by the pharmaceutical company Roche. Crystals are obtained by spray-drying the solution obtained from dissolving ketorolac in aqueous solutions of cellulose and fluorescein angiography. The crystals are stable over long periods of time, but may not dissolve completely when taken orally. Ketorolac tromethamine has been found to be biocompatible when used as an implant for the treatment of chronic pain.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 376.4 g/mol
• Formule: C₁₅H₁₃NO₃·C₄H₁₁NO₃
• Degré de pureté: Min. 95%